Literature DB >> 19840939

Mechanical loading regulates NFATc1 and beta-catenin signaling through a GSK3beta control node.

Buer Sen1, Maya Styner, Zhihui Xie, Natasha Case, Clinton T Rubin, Janet Rubin.   

Abstract

Mechanical stimulation can prevent adipogenic and improve osteogenic lineage allocation of mesenchymal stem cells (MSC), an effect associated with the preservation of beta-catenin levels. We asked whether mechanical up-regulation of beta-catenin was critical to reduction in adipogenesis as well as other mechanical events inducing alternate MSC lineage selection. In MSC cultured under strong adipogenic conditions, mechanical load (3600 cycles/day, 2% strain) inactivated GSK3beta in a Wnt-independent fashion. Small interfering RNA targeting GSK3beta prevented both strain-induced induction of beta-catenin and an increase in COX2, a factor associated with increased osteoprogenitor phenotype. Small interfering RNA knockdown of beta-catenin blocked mechanical reduction of peroxisome proliferator-activated receptor gamma and adiponectin, implicating beta-catenin in strain inhibition of adipogenesis. In contrast, the effect of both mechanical and pharmacologic inhibition of GSK3beta on the putative beta-catenin target, COX2, was unaffected by beta-catenin knockdown. GSK3beta inhibition caused accumulation of nuclear NFATc1; mechanical strain increased nuclear NFATc1, independent of beta-catenin. NFATc1 knockdown prevented mechanical stimulation of COX2, implicating NFATc1 signaling. Finally, inhibition of GSK3beta caused association of RNA polymerase II with the COX2 gene, suggesting transcription initiation. These results demonstrate that mechanical inhibition of GSK3beta induces activation of both beta-catenin and NFATc1 signaling, limiting adipogenesis via the former and promoting osteoblastic differentiation via NFATc1/COX2. Our novel findings suggest that mechanical loading regulates mesenchymal stem cell differentiation through inhibition of GSK3beta, which in turn regulates multiple downstream effectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840939      PMCID: PMC2787323          DOI: 10.1074/jbc.M109.039453

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase.

Authors:  Lluis Fajas; Stephanie Miard; Michael R Briggs; Johan Auwerx
Journal:  J Lipid Res       Date:  2003-07-01       Impact factor: 5.922

2.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

3.  Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential.

Authors:  Alexandra Peister; Jason A Mellad; Benjamin L Larson; Brett M Hall; Laura F Gibson; Darwin J Prockop
Journal:  Blood       Date:  2003-10-30       Impact factor: 22.113

4.  Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells.

Authors:  Hongyun Yan; Abdenaim Kermouni; Mohammed Abdel-Hafez; David C W Lau
Journal:  J Lipid Res       Date:  2002-11-04       Impact factor: 5.922

5.  Roles of Wnt/beta-catenin signaling in adipogenic differentiation potential of adipose-derived mesenchymal stem cells.

Authors:  Hui-Xia Li; Xiao Luo; Rong-Xin Liu; Ying-Juan Yang; Gong-She Yang
Journal:  Mol Cell Endocrinol       Date:  2008-05-17       Impact factor: 4.102

6.  Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable beta-catenin signal.

Authors:  Buer Sen; Zhihui Xie; Natasha Case; Meiyun Ma; Clinton Rubin; Janet Rubin
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

7.  Phosphorylation of C/EBPbeta at a consensus extracellular signal-regulated kinase/glycogen synthase kinase 3 site is required for the induction of adiponectin gene expression during the differentiation of mouse fibroblasts into adipocytes.

Authors:  Bae-Hang Park; Li Qiang; Stephen R Farmer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

8.  Beta-catenin levels influence rapid mechanical responses in osteoblasts.

Authors:  Natasha Case; Meiyun Ma; Buer Sen; Zhihui Xie; Ted S Gross; Janet Rubin
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

9.  Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.

Authors:  Katrina MacAulay; Eric Hajduch; Anne S Blair; Matthew P Coghlan; Stephen A Smith; Harinder S Hundal
Journal:  Eur J Biochem       Date:  2003-09

10.  NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure.

Authors:  R J Flockhart; B L Diffey; P M Farr; J Lloyd; N J Reynolds
Journal:  FASEB J       Date:  2008-08-15       Impact factor: 5.191

View more
  68 in total

1.  Stand UP!

Authors:  Janet Rubin; Clinton Rubin
Journal:  J Clin Endocrinol Metab       Date:  2010-05       Impact factor: 5.958

2.  Mechanical regulation of glycogen synthase kinase 3β (GSK3β) in mesenchymal stem cells is dependent on Akt protein serine 473 phosphorylation via mTORC2 protein.

Authors:  Natasha Case; Jacob Thomas; Buer Sen; Maya Styner; Zhihui Xie; Kornelia Galior; Janet Rubin
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

3.  Mechanical activation of β-catenin regulates phenotype in adult murine marrow-derived mesenchymal stem cells.

Authors:  Natasha Case; Zhihui Xie; Buer Sen; Maya Styner; Minxu Zou; Chris O'Conor; Mark Horowitz; Janet Rubin
Journal:  J Orthop Res       Date:  2010-11       Impact factor: 3.494

4.  Low magnitude mechanical signals mitigate osteopenia without compromising longevity in an aged murine model of spontaneous granulosa cell ovarian cancer.

Authors:  Gabriel M Pagnotti; Benjamin J Adler; Danielle E Green; M Ete Chan; Danielle M Frechette; Kenneth R Shroyer; Wesley G Beamer; Janet Rubin; Clinton T Rubin
Journal:  Bone       Date:  2012-05-11       Impact factor: 4.398

5.  Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells.

Authors:  William R Thompson; Christophe Guilluy; Zhihui Xie; Buer Sen; Kaitlyn E Brobst; Sherwin S Yen; Gunes Uzer; Maya Styner; Natasha Case; Keith Burridge; Janet Rubin
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

Review 6.  Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity.

Authors:  Gabriel M Pagnotti; Maya Styner; Gunes Uzer; Vihitaben S Patel; Laura E Wright; Kirsten K Ness; Theresa A Guise; Janet Rubin; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2019-06       Impact factor: 43.330

7.  Gene regulation through dynamic actin control of nuclear structure.

Authors:  Jeyantt Sankaran; Gunes Uzer; Andre J van Wijnen; Janet Rubin
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-13

8.  Actin up in the Nucleus: Regulation of Actin Structures Modulates Mesenchymal Stem Cell Differentiation.

Authors:  Janet Rubin; Buer Sen
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

9.  Indomethacin promotes adipogenesis of mesenchymal stem cells through a cyclooxygenase independent mechanism.

Authors:  Maya Styner; Buer Sen; Zhihui Xie; Natasha Case; Janet Rubin
Journal:  J Cell Biochem       Date:  2010-11-01       Impact factor: 4.429

10.  Conditional activation of β-catenin signaling in mice leads to severe defects in intervertebral disc tissue.

Authors:  Meina Wang; Dezhi Tang; Bing Shu; Baoli Wang; Hongting Jin; Suyang Hao; Karen A Dresser; Jie Shen; Hee-Jeong Im; Erik R Sampson; Paul T Rubery; Michael J Zuscik; Edward M Schwarz; Regis J O'Keefe; Yongjun Wang; Di Chen
Journal:  Arthritis Rheum       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.